BOSTON, May 9, 2019 /PRNewswire-PRWeb/ -- LeadingBiotech, an exclusive event series bringing biopharma CEOs and leaders
"We are excited about this year's Boston CEO event, which has been carefully curated to provide a more engaging experience for attendees focused on the industry's most relevant topics and trends," said LeadingBiotech CEO Wendy Nelson, Ph.D. "To highlight conference themes and key speakers, we've created an exclusive promotional soundbite. View our video here: https://lifesciences.knect365.com/biotech-ceo-boston/ "
Keynote speakers at the conference include George Church, Ph.D., Professor of Genomics, Harvard Medical School, who will speak on "Technologies for Reading & Editing Genomes;" Laurie Glimcher, M.D., President, CEO, Dana-Farber Cancer Institute, speaking on "Strategic Partnerships & Medical Research Funding;" and Jeff Jonas, M.D., CEO of Sage Therapeutics, discussing how 2019 is treating Sage as it comes off of promising data in the beginning of the year and what's next.
To learn more about our featured speakers and get a sneak peek at our promotional soundbite video, please visit our homepage: https://lifesciences.knect365.com/biotech-ceo-boston/
Additional featured speakers include:
A complete event agenda and registration information can be found here: https://lifesciences.knect365.com/biotech-ceo-boston/.
About LeadingBiotech Formerly known as Boston Biotech Conferences, LeadingBiotech is an event series that brings biopharma CEOs and leaders together through intimate, off-the-record collaboration. We're working hard to create more valuable experiences to re-energize collaboration and infuse fresh ideas to better shape the future of biotech. For more information, please visit: https://leadingbiotech.com/.
SOURCE Boston Biotech Conferences
Subscribe to our Free Newsletters!